206 related articles for article (PubMed ID: 22257864)
1. Resolvin E1 (RX-10001) reduces corneal epithelial barrier disruption and protects against goblet cell loss in a murine model of dry eye.
de Paiva CS; Schwartz CE; Gjörstrup P; Pflugfelder SC
Cornea; 2012 Nov; 31(11):1299-303. PubMed ID: 22257864
[TBL] [Abstract][Full Text] [Related]
2. Resolvin E1 improves tear production and decreases inflammation in a dry eye mouse model.
Li N; He J; Schwartz CE; Gjorstrup P; Bazan HE
J Ocul Pharmacol Ther; 2010 Oct; 26(5):431-9. PubMed ID: 20874497
[TBL] [Abstract][Full Text] [Related]
3. Protective effect of uridine on cornea in a rabbit dry eye model.
Oh JY; In YS; Kim MK; Ko JH; Lee HJ; Shin KC; Lee SM; Wee WR; Lee JH; Park M
Invest Ophthalmol Vis Sci; 2007 Mar; 48(3):1102-9. PubMed ID: 17325152
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness of topical infliximab in a mouse model of experimental dry eye.
Li Z; Choi W; Oh HJ; Yoon KC
Cornea; 2012 Nov; 31 Suppl 1():S25-31. PubMed ID: 23038030
[TBL] [Abstract][Full Text] [Related]
5. Sjögren's syndrome associated dry eye in a mouse model is ameliorated by topical application of integrin α4 antagonist GW559090.
Contreras-Ruiz L; Mir FA; Turpie B; Krauss AH; Masli S
Exp Eye Res; 2016 Feb; 143():1-8. PubMed ID: 26463157
[TBL] [Abstract][Full Text] [Related]
6. Topical cyclosporine inhibits conjunctival epithelial apoptosis in experimental murine keratoconjunctivitis sicca.
Strong B; Farley W; Stern ME; Pflugfelder SC
Cornea; 2005 Jan; 24(1):80-5. PubMed ID: 15604871
[TBL] [Abstract][Full Text] [Related]
7. Tear production and ocular surface changes in experimental dry eye after elimination of desiccating stress.
Yoon KC; Ahn KY; Choi W; Li Z; Choi JS; Lee SH; Park SH
Invest Ophthalmol Vis Sci; 2011 Sep; 52(10):7267-73. PubMed ID: 21849424
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of osmoprotectants on prevention and treatment of murine dry eye.
Chen W; Zhang X; Li J; Wang Y; Chen Q; Hou C; Garrett Q
Invest Ophthalmol Vis Sci; 2013 Sep; 54(9):6287-97. PubMed ID: 23970467
[TBL] [Abstract][Full Text] [Related]
9. Topical apolipoprotein A-1 may have a beneficial effect on the corneal epithelium in a mouse model of dry eye: a pilot study.
Nyunt AK; Ishida Y; Yu Y; Shimada S
Eye Contact Lens; 2008 Sep; 34(5):287-92. PubMed ID: 18779669
[TBL] [Abstract][Full Text] [Related]
10. Trehalose protects against ocular surface disorders in experimental murine dry eye through suppression of apoptosis.
Chen W; Zhang X; Liu M; Zhang J; Ye Y; Lin Y; Luyckx J; Qu J
Exp Eye Res; 2009 Sep; 89(3):311-8. PubMed ID: 19345212
[TBL] [Abstract][Full Text] [Related]
11. Resolvin E1 dampens airway inflammation and hyperresponsiveness in a murine model of asthma.
Aoki H; Hisada T; Ishizuka T; Utsugi M; Kawata T; Shimizu Y; Okajima F; Dobashi K; Mori M
Biochem Biophys Res Commun; 2008 Mar; 367(2):509-15. PubMed ID: 18190790
[TBL] [Abstract][Full Text] [Related]
12. A murine model of dry eye induced by an intelligently controlled environmental system.
Chen W; Zhang X; Zhang J; Chen J; Wang S; Wang Q; Qu J
Invest Ophthalmol Vis Sci; 2008 Apr; 49(4):1386-91. PubMed ID: 18385054
[TBL] [Abstract][Full Text] [Related]
13. D-beta-hydroxybutyrate protects against corneal epithelial disorders in a rat dry eye model with jogging board.
Nakamura S; Shibuya M; Nakashima H; Imagawa T; Uehara M; Tsubota K
Invest Ophthalmol Vis Sci; 2005 Jul; 46(7):2379-87. PubMed ID: 15980225
[TBL] [Abstract][Full Text] [Related]
14. Improvement of Outcome Measures of Dry Eye by a Novel Integrin Antagonist in the Murine Desiccating Stress Model.
Krauss AH; Corrales RM; Pelegrino FS; Tukler-Henriksson J; Pflugfelder SC; de Paiva CS
Invest Ophthalmol Vis Sci; 2015 Sep; 56(10):5888-95. PubMed ID: 26348638
[TBL] [Abstract][Full Text] [Related]
15. Topical TSG-6 Administration Protects the Ocular Surface in Two Mouse Models of Inflammation-Related Dry Eye.
Lee MJ; Kim DH; Ryu JS; Ko AY; Ko JH; Kim MK; Wee WR; Khwarg SI; Oh JY
Invest Ophthalmol Vis Sci; 2015 Aug; 56(9):5175-81. PubMed ID: 26244293
[TBL] [Abstract][Full Text] [Related]
16. Dry eye-induced conjunctival epithelial squamous metaplasia is modulated by interferon-gamma.
De Paiva CS; Villarreal AL; Corrales RM; Rahman HT; Chang VY; Farley WJ; Stern ME; Niederkorn JY; Li DQ; Pflugfelder SC
Invest Ophthalmol Vis Sci; 2007 Jun; 48(6):2553-60. PubMed ID: 17525184
[TBL] [Abstract][Full Text] [Related]
17. A mouse model of keratoconjunctivitis sicca.
Dursun D; Wang M; Monroy D; Li DQ; Lokeshwar BL; Stern ME; Pflugfelder SC
Invest Ophthalmol Vis Sci; 2002 Mar; 43(3):632-8. PubMed ID: 11867577
[TBL] [Abstract][Full Text] [Related]
18. Apical corneal barrier disruption in experimental murine dry eye is abrogated by methylprednisolone and doxycycline.
De Paiva CS; Corrales RM; Villarreal AL; Farley W; Li DQ; Stern ME; Pflugfelder SC
Invest Ophthalmol Vis Sci; 2006 Jul; 47(7):2847-56. PubMed ID: 16799024
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic Effect of MK2 Inhibitor on Experimental Murine Dry Eye.
Wu Y; Bu J; Yang Y; Lin X; Cai X; Huang C; Zheng X; Ouyang W; Li W; Zhang X; Liu Z
Invest Ophthalmol Vis Sci; 2017 Sep; 58(11):4898-4907. PubMed ID: 28973340
[TBL] [Abstract][Full Text] [Related]
20. Modulation of ocular surface desiccation in a murine model by histatin-5 application.
Ali M; Shah D; Coursey TG; Lee SM; Balasubramaniam A; Yadavalli T; Edward D; Son KN; Shukla D; Aakalu VK
Ocul Surf; 2023 Jan; 27():30-37. PubMed ID: 36513277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
